IPO snapshot · 5 Aug 2026
Last verified 6 Oct 2026This page preserves the IPO terms and company information available at listing. Later share prices and financial results are not included.
- Listing date
- 5 Aug 2026First day of trading
Company overview
Attovia Therapeutics websiteAttovia Therapeutics is a clinical-stage biopharmaceutical company. It is developing next-generation biotherapeutics for immune-mediated diseases with high unmet need.
- Company country
- United States
Offering details
Base offering, before overallotment
- Exchange
- Nasdaq Global Market
- Ticker
- ATTO
- Shares offered
- 17,000,000
- Shares after offering
- 43,029,017
- New shares
- 17,000,000
- Existing shares sold
- 0
IPO timeline
Filings and documents
- Listing announcementChecked 6 Oct 2026 (undated source)View document
- View document
- View document